A. Neubauer

1.3k total citations · 1 hit paper
22 papers, 921 citations indexed

About

A. Neubauer is a scholar working on Surgery, Hematology and Genetics. According to data from OpenAlex, A. Neubauer has authored 22 papers receiving a total of 921 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 5 papers in Hematology and 4 papers in Genetics. Recurrent topics in A. Neubauer's work include Chronic Lymphocytic Leukemia Research (3 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Acute Myocardial Infarction Research (3 papers). A. Neubauer is often cited by papers focused on Chronic Lymphocytic Leukemia Research (3 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Acute Myocardial Infarction Research (3 papers). A. Neubauer collaborates with scholars based in Germany, United States and United Kingdom. A. Neubauer's co-authors include Christian Thiede, E. Bayerdörffer, Norbert Lehn, M. Stolte, Sebastian Eidt, M. Group, Bernd Rudolph, Christos Haritoglou, A. Kampik and I. W. Reiniger and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

A. Neubauer

20 papers receiving 895 citations

Hit Papers

Regression of primary gastric lymphoma of mucosa-associat... 1995 2026 2005 2015 1995 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Neubauer Germany 7 479 396 319 202 187 22 921
P Blok Netherlands 21 758 1.6× 290 0.7× 521 1.6× 121 0.6× 207 1.1× 40 1.2k
John Chow China 13 221 0.5× 257 0.6× 155 0.5× 119 0.6× 259 1.4× 23 696
A. Moschini Italy 4 1.2k 2.5× 1.0k 2.6× 648 2.0× 435 2.2× 374 2.0× 6 2.0k
Manfred Stolte Germany 10 485 1.0× 145 0.4× 255 0.8× 95 0.5× 157 0.8× 11 640
H Steininger Germany 18 432 0.9× 57 0.1× 110 0.3× 256 1.3× 208 1.1× 37 887
Wing Y. Chan China 15 246 0.5× 253 0.6× 152 0.5× 167 0.8× 345 1.8× 25 802
Renzo Ranaldi Italy 14 274 0.6× 470 1.2× 253 0.8× 150 0.7× 260 1.4× 43 912
R A Robins United Kingdom 16 176 0.4× 218 0.6× 80 0.3× 232 1.1× 296 1.6× 31 815
M. E. Craanen Netherlands 18 706 1.5× 364 0.9× 458 1.4× 99 0.5× 554 3.0× 31 1.2k
Masakatsu Yonezumi Japan 12 168 0.4× 379 1.0× 98 0.3× 301 1.5× 198 1.1× 22 795

Countries citing papers authored by A. Neubauer

Since Specialization
Citations

This map shows the geographic impact of A. Neubauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Neubauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Neubauer more than expected).

Fields of papers citing papers by A. Neubauer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Neubauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Neubauer. The network helps show where A. Neubauer may publish in the future.

Co-authorship network of co-authors of A. Neubauer

This figure shows the co-authorship network connecting the top 25 collaborators of A. Neubauer. A scholar is included among the top collaborators of A. Neubauer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Neubauer. A. Neubauer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lux, Michael P., et al.. (2022). Budget impact of the Oncotype DX® test compared to other gene expression tests in patients with early breast cancer in Germany. Cancer Treatment and Research Communications. 31. 100519–100519. 7 indexed citations
2.
Reinöhl, Jochen, A. Neubauer, Ingo Ahrens, et al.. (2012). PCV38 Economic Evaluation of Anticoagulant Strategies in Interventional Treatment of Acute Myocardial Infarction. Value in Health. 15(7). A369–A369. 1 indexed citations
3.
Burchert, Andreas, Anja Lorch, J. T. Hartmann, et al.. (2010). Clinical relevance of germ cell cancer cells detected by real time PCR in apheresis products of poor risk patients undergoing high dose chemotherapy.. Journal of Clinical Oncology. 28(15_suppl). 4579–4579. 3 indexed citations
5.
Beyer, J., Anja Lorch, A. Neubauer, et al.. (2009). High-dose chemotherapy (HDCT) as second salvage treatment in patients with multiple relapsed or refractory germ cell tumors. Journal of Clinical Oncology. 27(15_suppl). 5082–5082.
6.
Schwarz, Franz, et al.. (2008). Langzeiterfolg der Koronarangioplastie nach wiederholten Eingriffen. DMW - Deutsche Medizinische Wochenschrift. 115(47). 1779–1782. 1 indexed citations
7.
Schwarz, Franz, et al.. (2008). Langzeiterfolg nach Koronarangioplastie in Abhängigkeit von der Gefäßgröße. DMW - Deutsche Medizinische Wochenschrift. 116(49). 1857–1861.
8.
Wündisch, Thomas, et al.. (2008). 10-year follow up of 120 patients with gastric MALT lymphoma after Helicobacter pylori eradication—Histological residual disease and second cancers. Journal of Clinical Oncology. 26(15_suppl). 8536–8536. 1 indexed citations
9.
Haritoglou, Christos, Ricarda G. Schumann, Rupert W. Strauß, et al.. (2007). Vitreoretinal surgery using bromphenol blue as a vital stain: evaluation of staining characteristics in humans. British Journal of Ophthalmology. 91(9). 1125–1128. 16 indexed citations
10.
Hirneiß, Christoph, A. Neubauer, I. W. Reiniger, et al.. (2006). Visual quality of life after macular hole surgery: outcome and predictive factors. British Journal of Ophthalmology. 91(4). 481–484. 56 indexed citations
11.
Neubauer, A., Kati Maharry, Guido Marcucci, et al.. (2005). Patients (pts) with acute myeloid leukemia (AML) and mutant RAS benefit from high-dose cytarabine (HDAC) intensification: A Cancer and Leukemia Group B (CALGB) study. Journal of Clinical Oncology. 23(16_suppl). 6514–6514. 3 indexed citations
12.
Eibl, K., et al.. (2004). Keratouveitis unklarer Genese. Der Ophthalmologe. 101(6). 629–30. 2 indexed citations
13.
Mueller, Martin, Peter Paschka, Tanja Lahaye, et al.. (2004). Molecular Long-Term Surveillance of CML Patients on Imatinib Therapy. Follow-Up of German Patients Treated within the IRIS Trial.. Blood. 104(11). 1003–1003. 1 indexed citations
14.
Seifart, Ulf, et al.. (2003). P-567 Topotecan/carboplatin 5 days versus topotecan/carboplatin 3 days in patients with metastasic small cell lung cancer. Lung Cancer. 41. S234–S235. 1 indexed citations
15.
Ritter, Markus, et al.. (1995). Detection of DNA methylation in the calcitonin gene in human leukemias using differential polymerase chain reaction.. PubMed. 9(5). 915–21. 13 indexed citations
16.
Bayerdörffer, E., Bernd Rudolph, A. Neubauer, et al.. (1995). Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. The Lancet. 345(8965). 1591–1594. 730 indexed citations breakdown →
17.
Scheffold, Christian, Karim J. Brandt, J R Johnston, et al.. (1995). Potential of autologous immunologic effector cells for bone marrow purging in patients with chronic myeloid leukemia.. PubMed. 15(1). 33–9. 52 indexed citations
19.
Przybylski, Grzegorz K., et al.. (1994). Ras point mutations occur in acute myeloid leukemia with illegitimate T-cell receptor delta gene rearrangement.. PubMed. 8(1). 102–5. 5 indexed citations
20.
Ball, Edward D., et al.. (1990). Detection of minimal acute myeloid leukemia cells in bone marrow by probing for mutated ras oncogenes using the polymerase chain reaction.. PubMed. 333. 499–506. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026